Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study

Abroad (travel likely)Recruiting

Conditions

Cancer Predisposition Syndrome · Predisposition, Genetic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Elizabeth ODonnell, MD) · elizabeth_odonnell@dfci.harvard.edu · 587-215-2361
Contact: Principal Investigator (Elizabeth ODonnell, MD)

Study leads

Elizabeth ODonnell, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Questionnaire on Congenital Cancer Signs Through Self-Assessment

Cancer Predisposition Syndromes · Pediatric Cancer · Childhood Neoplasms

Abroad (travel likely)Recruiting

Bern, Switzerland

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Cancer Risk · Cancer Predisposition Syndrome · Hereditary Cancer Prediction

Abroad (travel likely)Recruiting

Boston, United States

Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer

Neoplastic Syndromes, Hereditary · Cancer · Genetic Predisposition to Disease

Abroad (travel likely)Recruiting

Newcastle, Australia · Sydney, Australia